79 results
8-K
EX-99.1
NGM
Ngm Biopharmaceuticals Inc
11 Mar 24
NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
4:13pm
to customary closing conditions, and there can be no assurance that the Offer and the Merger contemplated by the
Merger Agreement will be completed
SC 14D9
NGM
Ngm Biopharmaceuticals Inc
8 Mar 24
Tender offer solicitation
5:21pm
and targets over the applicable periods. Accordingly, there can be no assurance that the Projections will be realized, and actual results may vary … or otherwise performed any procedures with respect to the Projections or expressed any opinion or any form of assurance with respect thereto
SC TO-T
EX-99
hva62g
8 Mar 24
Third party tender offer statement
4:53pm
SC TO-T
EX-99
l0h1rumv8gcs
8 Mar 24
Third party tender offer statement
4:53pm
8-K
EX-2.1
38n2n tkbkzm
26 Feb 24
NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
5:01pm
8-K
kiom8xyoc my9
2 Jan 24
Other Events
7:30am
424B5
6y6b 3v13yn
4 Aug 23
Prospectus supplement for primary offering
5:01pm
8-K
EX-1.1
ye3zg3a8g 1h4
8 Jun 23
Other Events
6:06am